Acute laryngitis superimposed on chronic laryngitis

February 25, 2013     David N. Myerson, MD; Rima A. DeFatta, MD; Robert T. Sataloff, MD, DMA, FACS

Radiation-induced fibrosis can be found in tissues of the neck, pharynx, larynx, esophagus, ear, and temporomandibular joint. It is associated histologically with aggregates of macrophages, fibroblasts, vascular connective tissue changes, and deposition of extracellular matrix. This fibrosis can lead to strictures, stenosis, trismus, ulcerations, and scarring, which can present as dysphagia and dysphonia.

Thyroid cartilage fracture following percutaneous tracheotomy tube placement

December 31, 2012     Jaime Eaglin Moore, MD and Andrew Heller, MD

Patients whose body mass index (BMI) is 30 or greater have a higher likelihood of a distorted anatomy, which can make tracheotomy tube placement difficult.

Vocal fold atrophy and Reinke edema

October 8, 2012     Eliana Verghese, MD; Rima A. DeFatta, MD; Robert T. Sataloff, MD, DMA, FACS

If voice therapy does not improve vocal fold atrophy and muscle tension dysphonia, then medialization laryngoplasty by injection or thyroplasty may be indicated. 

Rosai-Dorfman disease with isolated laryngeal involvement

October 4, 2012     Elisa A. Illing, MD; Stacey L. Halum, MD


Rosai-Dorfman disease is a rare histiocyte disorder that is typically characterized by massive cervical lymphadenopathy. Isolated extranodal involvement is uncommon, and isolated laryngeal involvement is extremely rare. We report an unusual case of Rosai-Dorfman disease with isolated laryngeal involvement that led to recurrent dysphonia and airway obstruction. We discuss the challenges we faced in reaching a correct pathologic diagnosis and in deciding on an appropriate treatment regimen. Based on our experience, we believe that Rosai-Dorfman disease should be considered as a differential diagnosis in patients who present with a recurrent inflammatory (histiocytic) mass lesion of the larynx.

Laryngeal papilloma

April 30, 2012     Rima A. DeFatta, MD; Johnathan B. Sataloff; Grace E. Klaris; Robert T. Sataloff, MD, DMA, FACS

Anterior and posterior glottic webs

July 13, 2011     Jennifer M. Cannady, MA CCC-SLP and Lee A. Reussner, MD

Reinke edema: Signs, symptoms, and findings on strobovideolaryngoscopy

March 31, 2011     Danielle Gainor, MD, Farhad R. Chowdhury, DO, and Robert T. Sataloff, MD, DMA, FACS

Laryngeal paraganglioma

September 30, 2010     Yoav Hahn, MD, Richard Isaacs, MD, and Peter C. Belafsky, MD, PhD

Acute dysphonia secondary to vocal fold hemorrhage after vardenafil use

May 31, 2010     Vikas Singh, MD, Seth M. Cohen, MD, MPH, Bernard Rousseau, PhD, J. Pieter Noordzij, MD, C. Gaelyn Garrett, MD, and Robert H. Ossoff, DMD, MD


Owing to their vasodilatory effects, the phosphodiesterase-5 inhibitors have become widely used for the treatment of erectile dysfunction. Among the reported adverse events of these agents are epistaxis, variceal bleeding, intracranial hemorrhage, and hemorrhoidal bleeding. We report a case of vocal fold hemorrhage that occurred after vardenafil use in a 31-year-old man who was a professional singer.

Type 2 sulcus vocalis: Sulcus vergeture

January 1, 2010     Edward J. Damrose, MD, FACS

Jugular fossa meningioma: Presentation and treatment options

September 30, 2009     Amy L. Rutt, DO, Xiaoli Chen, MD, and Robert T. Sataloff, MD, DMA, FACS


Primary jugular fossa meningiomas are among the rarest subtypes of meningioma. They are intimately related to the lower cranial nerves, the jugular bulb and vein, and the temporal bone, and they have a tendency to extend both intra- and extracranially. The most common morbidity associated with jugular fossa lesions is lower cranial nerve deficits. In these cases, the differential diagnosis and preoperative radiographic diagnosis are very important because preoperative management and operative planning for the jugular fossa subtype differ considerably from those of other types of meningioma. Because of the rarity of this condition, our understanding of its treatment, long-term follow-up, and recurrence is limited. As experience with radiosurgical treatment of all meningiomas is accumulating, we may find that radiosurgery of jugular fossa meningiomas is appropriate. In the meantime, cure is still possible with complete surgical resection, and surgical morbidity can be minimized through meticulous planning and surgical technique. We describe a case of primary jugular fossa meningioma in a 45-year-old man who presented with complaints of chronic left aural fullness, hearing loss, and difficulty understanding voices. Imaging revealed the presence of a destructive jugular fossa mass. The patient underwent surgical resection without complication, and he was free of recurrence at 1 year of follow-up.

A survey of current practices of physicians who treat adductor spasmodic dysphonia in the U.S.

April 30, 2009     Christopher Y. Chang, MD, Peter Chabot, PhD, and Christopher M. Walz, MD


We conducted a survey to determine the current practices of a subset of physicians in the United States who treat patients with adductor spasmodic dysphonia. Surveys were sent to 169 physicians listed in the National Spasmodic Dysphonia Association database, and responses were returned by 43 (25.4%). Almost all respondents (95.4%) indicated that they use botulinum toxin type A injections, either alone or in combination with other treatments, to treat adductor spasmodic dysphonia, and most (69.8%) inject the toxin under electromyographic guidance. However, there were wide variations in the amount of sterile saline used to reconstitute the toxin, the size of the initial dose, and the use of other treatment strategies.

of 3Next